TNDM Tandem Diabetes Market Value to Book Value Ratio

Tandem Diabetes - graphic logo of issuer TNDM

The confirmed price history on the Tandem Diabetes Care (TNDM) chart demonstrates metrics at the level of 10.26. Tandem Diabetes Care develops insulin delivery systems, the growth of which relies on the digitalization of therapy and insurance coverage. Professional management ensures the expansion of brands into global markets. Demand is supported by wearable devices that mimic pancreatic function, which are rapidly displacing outdated analogs in diabetes treatment.

Tandem Corp (TNDM) Market Capitalization to Net Assets: for the period 07/04/2022 - 10/31/2026
Flagship merchandise of Tandem Diabetes Care Inc

This indicator measures the premium of a business's market value over its net assets, allowing for the determination of the degree of capital overvaluation or undervaluation. Analyzing the market cap to book value ratio helps investors assess the resource management efficiency of Tandem Diabetes Care (TNDM), where cost optimization through the outsourcing of production and logistics directly impacts equity dynamics and final market value.

Competitor analysis

Boston Scientific (BSX) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio edwards.com|Market Value to Book Value Ratio ResMed|Insulet Corp (PODD) - Market Capitalization to Book Value|Market Value to Book Value Ratio Zimmer Biomet Holdings, Inc. (ZBH)|COO: Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio ALGN (Align Technology, Inc.)|globusmedical.com (GMED) - Market-to-Book Ratio|TransMedics Group - Market Capitalization to Book Value Ratio|Alphatec Holdings (ATEC) - Market Cap to Net Assets Ratio|AORT: Market Capitalization to Book Value Ratio|ENOV - Market Capitalization to Book Value|IART (Integra LifeSciences) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio establishmentlabs.com|Market Value to Book Value Ratio Beta Bionics (BBNX)|Market Value to Book Value Ratio IRMD (IRADIMED Corp)|Market Capitalization to Book Value Ratio EMBC (Embecta Inc.)|Market Capitalization to Book Value Axogen Surgical (AXGN)|SIBN: Market Cap to Net Assets Ratio|Market Capitalization to Net Assets OFIX|BVS: Market Capitalization to Book Value Ratio|Market-to-Book Ratio OrthoPediatrics (KIDS)|TMCI (Treace Medical) - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio SRTA (Strata Medical)|Market Cap to Net Assets Ratio CARL (Carlsmed Inc)|RXST (rxsight.com) - Market Value to Book Value|Market Value to Book Value Ratio ClearPoint Neuro CLPT|STXS - Market Cap to Net Assets Ratio|NeuroStar - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Sight Sciences Inc|OBIO: Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio ANIK|NSPR (InspireMD) - Market Capitalization to Book Value Ratio|Jin Medical International Ltd (ZJYL) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio VANI|Market Cap to Net Assets Ratio xtantmedical.com XTNT|Market Capitalization to Book Value Ratio NMTC (NeuroOne Medical Technologies)|Market Capitalization to Book Value Ratio Modular Medical Inc MODD|MYO - Market Value to Book Value Ratio|COCH: Market Value to Book Value Ratio|VVOS (Vivos Therapeutics, Inc) - Market Cap to Net Assets Ratio|enVVeno Corp - Market Value to Book Value|SINT (Sintx Technologies Inc) - Market Capitalization to Book Value Ratio|Market-to-Book Ratio tenonmed.com TNON|Market Value to Book Value Ratio Lifeward (LFWD)|autonomix.com (AMIX) - Market Value to Equity Ratio|INVO Bioscience, Inc. - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio Bone Biologics Inc BBLG|Axonics, Inc. - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value biolase.com BIOL|dynatronics.com (DYNT) - Market Value to Book Value Ratio|Market Capitalization to Net Assets FNA (Paragon 28)|Market Value to Book Value Ratio INVO Bioscience Inc.